Prescribing information in 26 countries: A comparative study

European Journal of Clinical Pharmacology

Volumn 59, Issue 4, 2003, Pages 263-270

  Reggi, V ^a   Balocco Mattavelli, R ^a   Bonati, M ^b   Breton, I ^c   Figueras, A ^d   Jambert, E ^a   Kopp, C ^c   Montane, E ^d   Rago L ^a   Rocchi, F ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c International Society Drug Bulletins   (France)

^d Fundacion Institut Catala de Farmacologia   (Spain)

Author keywords

Drug information; International survey; Regulatory affairs

Indexed keywords

CELECOXIB; CIPROFLOXACIN; CISAPRIDE; FLUOXETINE; MONTELUKAST; NIFEDIPINE;

ADULT; ARTICLE; COMPARATIVE STUDY; DRUG INDICATION; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; DRUG USE; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT INDICATION;

DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG LABELING; INTERNATIONAL COOPERATION; PHARMACOPOEIAS;

EID: 10744224971     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-003-0607-1     Document Type: Article

References (13)

1. Curran CF (2000) A progress report: Drug information from 1970 to 2000. Drug Inf J 34:1355-1363
2. Garattini S (1998) How to improve medical information on drugs. Lancet 352:151-152
3. Mindell J, Kemp T (1997) Only two fifths of advertisements cited published, peer reviewed references. BMJ 315:1622
4. Stryer D, Bero LA (1996) Characteristics of materials distributed by drug companies: an evaluation of appropriateness. J Gen Intern Med 11:575-583
5. Bradley B, Singleton M, Li Wan Po A (1994) Readability of patient information leaflets on over-the-counter (OTC) medicines. J Clin Pharm Ther 19:7-15
6. Holt GA, Dorcheus L, Hall EL, Beck D, Ellis E, Hough J (1992) Patient interpretation of label instructions. Am Pharm NS 32:58-62
7. Gibbs S, Waters WE, George FC (1989) The benefits of prescription information leaflets (2). Br J Clin Pharmacol 28:345-351
8. Dikshit RK, Dikshit N (1994) Commercial source of drug information: comparison between the UK and India. BMJ 309:990-991
9. Anonymous (2002) Scrip's 2002 Yearbook, vol 1, PJB Publications Ltd., USA
10. World Health Organization (2002) The World Health Report 2002: reducing risks, promoting healthy life. WHO, Geneva. Available from: URL:http://www3.who.int/whosis/menu.cfm.
11. The British Medical Association and the Royal Pharmaceutical Society of Great Britain (2000) British National Formulary. London, UK
12. AHFS drug information (2001) American Society of Health-System Pharmacists, ISSN 8756-6028
13. Thompson AE, Shea B, Welch V, Fenlon D, Pope JE (2001) Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. Arthritis Rheum Aug 44:1841-1847